Pro 2014-021 (Xianfeng Project Framework of Jianfeng Group)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: 2014-021
Bond Abbreviation: 13 Jianfeng 01 Bond Code: 122227
Zhejiang Jianfeng Group Co., Ltd.
Reminder Announcement on Signing Investment Framework Agreement
The board of directors and all directors of the company guarantee that the content of this announcement does not contain any False records, misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents .
Important Note:
l Company has signed a framework agreement with Xianfeng County People's Government. plans to organize investment in Xianfeng County, Enshi Prefecture, Hubei Province. The initial scale of the project is planned to produce 2500t/d cement clinker production line on .
l This time signed a framework agreement, which is a preliminary arrangement for project approval and certification. The implementation of the investment plan still needs to perform the decision-making procedures of the board of directors in accordance with relevant laws and regulations and the company's "Articles of Association. The cement production line project to be invested and constructed still needs to be publicized by the government, approved announcement, feasibility study report review and other procedures. There are certain uncertainties in the scale of the project, whether the project can be approved and whether it can be successfully implemented.
1. Overview
Recently, Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "Jianfeng Group" or "Company") and Xianfeng County People's Government (hereinafter referred to as "Xianfeng County Government") signed the "Framework Agreement on Investment and Construction of Cement Production Line Project" (hereinafter referred to as the "Framework Agreement"). The company intends to invest in the cement production line project in Xianfeng County, Enshi Prefecture, Hubei Province.
The framework agreement signed this time is a preliminary arrangement for project approval. The implementation of the investment plan still needs to perform the decision-making procedures of the board of directors in accordance with relevant laws and regulations and the company's "Articles of Association.
The company does not have an associated relationship with the Xianfeng County Government. The signing of the framework agreement does not constitute a related transaction, nor does it constitute a major asset reorganization as stipulated in the "Administrative Measures for the Major Asset Reorganization of Listed Companies.
Main Body of 2. Framework Agreement
Party A: Xianfeng County People's Government
Party B: Zhejiang Jianfeng Group Co., Ltd.
Main Contents of 3. Framework Agreement
. Party B plans to invest in cement project in Xianfeng County. The preliminary scale of the project is planned as follows: the daily production of 2500t/d cement clinker production line is located in Xianfeng County.
2. Party B intends to organize investment to establish a subsidiary with independent legal personality in Xianfeng County. The company is temporarily named Enshi Jianfeng Cement Co., Ltd. (subject to industrial and commercial registration).
3. According to Party A's request, Party B agrees to open a bank account in Xianfeng County and inject RMB 20 million yuan in order to show its sincerity in investment.
4. Party A shall strive for the project to enter the Hubei cement industry structure adjustment plan and include it in the first batch of public announcements.
5. After the project is announced by the Hubei Provincial People's Government or its designated agency, Party B shall set up a project preparation team to carry out project certification, declaration and other preliminary work together with Party A.
6. Party A shall create good conditions for the project inspection, certification, declaration, construction and operation of Party B (or its subsidiaries), and provide the greatest support and the most favorable policies. And in accordance with the "one factory, one policy" approach, to ensure and be responsible for the allocation of land, water, electricity, roads, ore and other resources required by the project.
7. In the process of project application, approval, construction and production and operation, Party A shall actively coordinate with relevant parties and give support and cooperation to Party B.8. After approval and publicity by relevant government departments, the two parties will sign a formal agreement on the specific matters of the project, and perform the decision-making procedures such as the board of directors in accordance with relevant laws and regulations and the company's "Articles of Association.
4. Purpose and Impact on the Company
Xianfeng County, Enshi Prefecture, Hubei Province has a good location advantage, with abundant resources required for cement production such as limestone, coal, coal gangue and sandstone, and more infrastructure projects are planned in and around it. If the investment plan can be implemented smoothly, it will help to further expand the company's production and operation scale and expand and strengthen the company's cement business.
5. Risks
This time, the framework agreement is signed, which is a preliminary arrangement for project approval. The implementation of the investment plan still needs to be in accordance with relevant laws and regulations and The company's "Articles of Association" stipulates that the decision-making procedures such as the board of directors shall be performed. The cement production line project to be invested and constructed still needs to be publicized by the government, approved announcement, feasibility study report review and other procedures. There are certain uncertainties in the scale of the project, whether the project can be approved and whether it can be successfully implemented. Investors should pay attention to investment risks.
6. Reference Document
"Framework Agreement on Investment and Construction of Cement Production Line Project"
This is to announce
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
July 31, 2014
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31